Tipsheet
What matters at India’s listed companies
Earnings · Hospital & Healthcare · Large cap

Fortis Healthcare approves Q4 results and a ₹1 dividend

The company posted year-on-year growth for FY2026, but the filing contains no material surprises for investors.

7 earlier stories on Fortis Healthcare Ltd.
Mkt cap₹72,083 cr
P/E69.19×
ROE8.68%
Debt / eq.0.25
Div yld0.10%
₹1 per share Final dividend recommended by the board.

What's new

  • Board approved audited standalone and consolidated financial results for Q4 and FY2026.
  • Statutory auditors issued an unmodified opinion on the annual accounts.
  • Company announced a final dividend of ₹1 per share alongside routine procedural appointments.

Why this matters

The results show growth, but they also reflect exactly what the market expected. There are no new strategic shifts or unexpected operational updates here to change the investment case.

What we're watching

  • Whether the upcoming earnings call details any new margin pressure.
  • The timeline for the final dividend payout.
  • Any management commentary on hospital occupancy rates.

The full read

Fortis Healthcare cleared its board meeting today with the expected approval of Q4 and FY2026 audited results. The numbers show year-on-year growth in both revenue and net profit, confirming the trajectory the market had already baked in. Auditors provided a clean, unmodified opinion on the books. Alongside the financials, the board recommended a final dividend of ₹1 per share and settled standard procedural items like the appointment of a cost auditor and updates to its CSR policy. These are administrative staples that move the needle for no one. With no new strategic or operational updates to report, this filing is a routine check-in. It provides the necessary data for the year but offers nothing in the way of a surprise.

Questions answered

Did the auditors flag any issues with the financial results?
No. The statutory auditors issued an unmodified opinion on the financial statements.
Was there any new strategic guidance provided?
No. The filing was limited to standard financial results and routine board procedural matters.
Mentioned: Fortis Healthcare · FY2026 · Q4
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Fortis Healthcare Ltd.

Hospitals
₹73,586 cr
P/E 70.63×

Latest quarter · Mar 2026

Sales₹2,365 cr
Net profit₹265 cr
Op. margin+22.5%
EPS₹3.52

Strength & growth

Debt / equity0.25×
Current ratio0.92×
Sales CAGR+8.1%
EPS CAGR+42.3%
Financials via Tijori — a research aid, not investment advice.FORTIS on Tijori
  1. 22 May 2026 · 7:56 PM IST Fortis Healthcare approves Q4 results and a ₹1 dividend
  2. 7d ago Fortis Healthcare enters Odisha with asset-light hospital deal
  3. 49d ago Fortis Healthcare reports 31.5% profit growth for FY26
  4. 49d ago Fortis Healthcare profits climb 31% on double-digit revenue growth
  5. 49d ago Fortis Healthcare confirms final dividend of ₹1 per share